EX-10.1 2 d541282dex101.htm EX-10.1 ***Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under Execution Version Amended and Restated Ex-US Commercialization Agreement This Amended and...Ex-Us Commercialization Agreement • May 5th, 2020 • New York
Amended and Restated Ex-US Commercialization AgreementEx-Us Commercialization Agreement • July 18th, 2018 • Foundation Medicine, Inc. • Services-medical laboratories • New York
WHEREAS, FMI has certain products that it currently commercializes, and additional products that it would like to commercialize in the future, either by itself or through a collaborator;